அறிவாற்றல் சோர்வு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from அறிவாற்றல் சோர்வு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In அறிவாற்றல் சோர்வு Today - Breaking & Trending Today

New study to examine the effects of MS disease-modifying therapy on cognitive fatigue


New study to examine the effects of MS disease-modifying therapy on cognitive fatigue
Kessler Foundation researchers have received support from Genentech, a member of the Roche Group, to conduct an investigator-initiated study on the effects of ocrelizumab (Ocrevus) on cognitive fatigue in individuals with relapsing-remitting multiple sclerosis (MS).
John DeLuca, PhD, senior vice president of Research and Training, is principal investigator for the study titled, A Biomarker for Cognitive Fatigue in MS using Functional Imaging . The study team includes Glenn Wylie, DPhil, director of the Rocco Ortenzio Neuroimaging Center at Kessler Foundation, Ekaterina Dobryakova, PhD, research scientist in the Center for Traumatic Brain Injury Research, and Helen Genova, PhD, assistant director of the Center for Neuropsychology and Neuroscience Research. ....

Helen Genova , Ekaterina Dobryakova , Glenn Wylie , John Deluca , Emily Henderson , Rocco Ortenzio Neuroimaging Center At Kessler Foundation , Kessler Foundation , Roche Group , Neuroscience Research , Ortenzio Center , Traumatic Brain Injury Research , Cognitive Fatigue , Rocco Ortenzio Neuroimaging Center , Medical School , Multiple Sclerosis , Relapsing Remitting Multiple Sclerosis , ஹெலன் ஜெனோவா , க்ளென் வைலீ , ஜான் டெழுகே , எமிலி ஹென்டர்சன் , கெஸ்லர் அடித்தளம் , ரோச் குழு , நரம்பியல் ஆராய்ச்சி , அதிர்ச்சிகரமான மூளை காயம் ஆராய்ச்சி , அறிவாற்றல் சோர்வு , மருத்துவ பள்ளி ,

Kessler Foundation to study effects of MS disease-modifying therapy on cognitive fatigue


 E-Mail
IMAGE: Dr. DeLuca is senior vice president of Research and Training at Kessler Foundation and professor of neurology and physical medicine and rehabilitation at Rutgers New Jersey Medical School. He.
view more 
Credit: Kessler Foundation
East Hanover, NJ. February 8, 2021 - Kessler Foundation researchers have received support from Genentech, a member of the Roche Group, to conduct an investigator-initiated study on the effects of ocrelizumab (Ocrevus) on cognitive fatigue in individuals with relapsing-remitting multiple sclerosis (MS).
John DeLuca, PhD, senior vice president of Research and Training, is principal investigator for the study titled, A Biomarker for Cognitive Fatigue in MS using Functional Imaging . The study team includes Glenn Wylie, DPhil, director of the Rocco Ortenzio Neuroimaging Center at Kessler Foundation, Ekaterina Dobryakova, PhD, research scientist in the Center for Traumatic Brain Injury Research, and Helen Genova ....

Helen Genova , Ekaterina Dobryakova , Glenn Wylie , Carolann Murphy , John Deluca , Rocco Ortenzio Neuroimaging Center At Kessler Foundation , Kessler Foundation , Ortenzio Center , Traumatic Brain Injury Research , Roche Group , Neuroscience Research , East Hanover , Cognitive Fatigue , Rocco Ortenzio Neuroimaging Center , Health Care , Medicine Health , Clinical Trials , Pharmaceutical Science , Rehabilitation Prosthetics Plastic Surgery , Disabled Persons , Memory Cognitive Processes , ஹெலன் ஜெனோவா , க்ளென் வைலீ , கரோலன் மர்பி , ஜான் டெழுகே , கெஸ்லர் அடித்தளம் ,